Wednesday, February 18

Omnigeniq’s journey from space science to drug design


Newco news

A project that started as a bioreactor to assist astronauts in deep space to keep medications safe in a microgravity environment could help pharma companies model how drugs behave in the human body. Omnigeniq unveiled at the J.P. Morgan Healthcare conference the first computer model of a human protein as it exists in the body, confirming that native protein topology can be calculated directly from physics.

BioWorld Newco news Cancer Asia-Pacific Australia



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *